en

PRODUCT DETAIL

Xtandi 40 mg filmom obalené tablety

Code 5396C
MA number EU/1/13/846/002
Product Form: tbl flm 112(4x28)x40 mg (blis.PVC/PCTFE/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BB Anti-androgens
L02BB04 Enzalutamide
Shelf life: 48
Container: blister PVC/PCTFE/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 21.09.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 09.03.2023
eu-flag.png sk-flag.png